301 related articles for article (PubMed ID: 19423014)
21. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
22. Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action.
Ohta H; Ishizaka T; Tatsuzuki M; Yoshinaga M; Iida I; Yamaguchi T; Tomishima Y; Futaki N; Toda Y; Saito S
Bioorg Med Chem; 2008 Feb; 16(3):1111-24. PubMed ID: 18006322
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
[TBL] [Abstract][Full Text] [Related]
24. Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.
Fuchigami T; Haradahira T; Fujimoto N; Nojiri Y; Mukai T; Yamamoto F; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
Bioorg Med Chem; 2009 Aug; 17(15):5665-75. PubMed ID: 19586774
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging.
Evens N; Vandeputte C; Muccioli GG; Lambert DM; Baekelandt V; Verbruggen AM; Debyser Z; Van Laere K; Bormans GM
Bioorg Med Chem; 2011 Aug; 19(15):4499-505. PubMed ID: 21737287
[TBL] [Abstract][Full Text] [Related]
26. Sulfonamide derivatives as new potent and selective CB2 cannabinoid receptor agonists.
Ohta H; Ishizaka T; Yoshinaga M; Morita A; Tomishima Y; Toda Y; Saito S
Bioorg Med Chem Lett; 2007 Sep; 17(18):5133-5. PubMed ID: 17643986
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.
Muccioli GG; Wouters J; Charlier C; Scriba GK; Pizza T; Di Pace P; De Martino P; Poppitz W; Poupaert JH; Lambert DM
J Med Chem; 2006 Feb; 49(3):872-82. PubMed ID: 16451053
[TBL] [Abstract][Full Text] [Related]
28. Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.
Mavel S; Vercouillie J; Garreau L; Raguza T; Ravna AW; Chalon S; Guilloteau D; Emond P
Bioorg Med Chem; 2008 Oct; 16(19):9050-5. PubMed ID: 18793858
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies.
Lange JH; van der Neut MA; Wals HC; Kuil GD; Borst AJ; Mulder A; den Hartog AP; Zilaout H; Goutier W; van Stuivenberg HH; van Vliet BJ
Bioorg Med Chem Lett; 2010 Feb; 20(3):1084-9. PubMed ID: 20031412
[TBL] [Abstract][Full Text] [Related]
30. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists.
Raitio KH; Savinainen JR; Vepsäläinen J; Laitinen JT; Poso A; Järvinen T; Nevalainen T
J Med Chem; 2006 Mar; 49(6):2022-7. PubMed ID: 16539390
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Behrenswerth A; Volz N; Toräng J; Hinz S; Bräse S; Müller CE
Bioorg Med Chem; 2009 Apr; 17(7):2842-51. PubMed ID: 19278853
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors.
Ferrarini PL; Calderone V; Cavallini T; Manera C; Saccomanni G; Pani L; Ruiu S; Gessa GL
Bioorg Med Chem; 2004 Apr; 12(8):1921-33. PubMed ID: 15051060
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of fluorine-substituted 1H-pyrrolo[2,3-b]pyridine derivatives for dopamine D4 receptor imaging.
Oh SJ; Lee KC; Lee SY; Ryu EK; Saji H; Choe YS; Chi DY; Kim SE; Lee J; Kim BT
Bioorg Med Chem; 2004 Nov; 12(21):5505-13. PubMed ID: 15465327
[TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of endothelin-A receptor (radio)ligands for positron emission tomography.
Michel K; Büther K; Law MP; Wagner S; Schober O; Hermann S; Schäfers M; Riemann B; Höltke C; Kopka K
J Med Chem; 2011 Feb; 54(4):939-48. PubMed ID: 21275367
[TBL] [Abstract][Full Text] [Related]
37. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee CM; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
Neuroimage; 2008 Jul; 41(3):1075-85. PubMed ID: 18434202
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro evaluation of (18)F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET.
Robins EG; Zhao Y; Khan I; Wilson A; Luthra SK; Rstad E
Bioorg Med Chem Lett; 2010 Mar; 20(5):1749-51. PubMed ID: 20138515
[TBL] [Abstract][Full Text] [Related]
39. New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists.
Manera C; Cascio MG; Benetti V; Allarà M; Tuccinardi T; Martinelli A; Saccomanni G; Vivoli E; Ghelardini C; Di Marzo V; Ferrarini PL
Bioorg Med Chem Lett; 2007 Dec; 17(23):6505-10. PubMed ID: 17942307
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.
Höhne A; Mu L; Honer M; Schubiger PA; Ametamey SM; Graham K; Stellfeld T; Borkowski S; Berndorff D; Klar U; Voigtmann U; Cyr JE; Friebe M; Dinkelborg L; Srinivasan A
Bioconjug Chem; 2008 Sep; 19(9):1871-9. PubMed ID: 18754574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]